Transgenic mice expressing an α-secretion mutant of the amyloid precursor protein in the brain develop a progressive CNS disorder

Behavioural Brain Research

Volumn 95, Issue 1, 1998, Pages 55-64

  Moechars, Dieder ^a   Lorent, Kristin ^a   Dewachter, Ilse ^a   Baekelandt, Veerle ^a   De Strooper, Bart ^a   Van Leuven, Fred ^a  

^a Campus Gasthuisberg O and N 06   (Belgium)

Author keywords

Alzheimer's disease; Amyloid precursor protein (APP); Glutamate; Neophobic; NMDA; Open field test; Transgenic mouse

Indexed keywords

AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; FEMALE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; AUTORADIOGRAPHY; BLOTTING, WESTERN; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MUTATION; RECEPTORS, N-METHYL-D-ASPARTATE; SILVER STAINING;

EID: 0032167860     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)00210-6     Document Type: Article

References (62)

1. Buxbaum JD, Christensen JL, Ruefli AA, Greengard P, Loring JF Expression of APP in brains of transgenic mice containing the entire human APP gene. Biochem Biophys Res Commun. 197:1993;639-645.
2. Games D, Adams D, Alessandrini R et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
3. Howland DS, Savage MJ, Huntress FA, Wallace RE, Schwartz DA, Loh T, Melloni RH Jr, DeGennaro LJ, Greenberg BD, Siman R, Swanson M, Scott R Mutant and native human β-amyloid precursor proteins in transgenic mouse brain. Neurobiol Aging. 16:1995;685-699.
4. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D, Iadecola C, Clark H, Carlson G Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron. 15:1995;1203-1218.
5. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
6. Kammesheidt A, Boyce FM, Spanoyannis AF, Cummings BJ, Ortegon M, Cotman C, Vaught JL, Neve RL Deposition of βA4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci USA. 89:1992;10857-10861.
7. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat Genet. 9:1995;21-29.
8. Lamb BT, Sisodia SS, Lawler AM, Slunt HH, Kitt CA, Kearns WG, Pearson PL, Price DL, Gearhart JD Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nat Genet. 5:1993;22-30.
9. Moechars D, Lorent K, De Strooper B, Dewachter I, Van Leuven F Expression in brain of amyloid precursor protein mutated in the α-secretase site, causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 15:1996;1265-1274.
10. Mucke L, Masliah E, Johnson WB, Ruppe MD, Alford M, Rockenstein EM, Fross-Petter S, Pietropaolo M, Mallory M, Abraham CR Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res. 666:1994;151-167.
11. Pearson BE, Choi TK Expression of the human β-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice. Proc Natl Acad Sci USA. 90:1993;10578-10582.
12. Quon D, Wang Y, Catalano R, Scardina M, Murakami K, Cordell B Formation of β-amyloid protein deposits in brains of transgenic mice. Nature. 352:1991;239-241.
13. Yamaguchi F, Richards SJ, Beyreuther K, Salbaum M, Carlson GA, Dunnett SB Transgenic mice for the human amyloid precursor protein 695 isoform have impaired spatial memory. Neuroreport. 2:1991;781-784.
14. Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature. 331:1988;530-532.
15. Milward EA, Papadopoulos R, Fuller SJ, Moir RD, Small D, Beyreuther K, Masters CL The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron. 9:1992;129-137.
16. Nishimoto I, Okamoto T, Matsuura Y, Takahashi S, Okamoto T, Murayama Y, Ogata E Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go. Nature. 362:1993;75-79.
17. Mattson MP, Cheng P, Culwell AR, Esch FS, Lieberburg I, Rydel RE Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron. 10:1993;243-254.
18. Glenner GG, Wong CW Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 122:1984;1131-1135.
19. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald B, Beyreuther K Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA. 82:1985;4245-4249.
20. Goldgaber D, Lerman MI, McBride OW, Saffiotti U, Gajdusek DC Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science. 235:1987;877-880.
21. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K, Müller-Hill B The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
22. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, McClure D, Ward PJ Cleavage of amyloid β-peptide during constitutive processing of its precursor. Science. 248:1990;1122-1124.
23. Haass C, Selkoe DJ Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide. Cell. 75:1993;1039-1042.
24. Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL Amyloid A4 protein and its precursors in Down's syndrome and Alzheimer's disease. New Engl J Med. 320:1989;1446-1452.
25. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature. 353:1991;844-846.
26. Goate A, Chartier-Harlin MC, Mullan M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 349:1991;704-706.
27. Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, Warren A, McInnis MG, Antonarakis SE, Martin JJ, Hofman A, Van Broeckhoven C Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat Genet. 1:1992;218-222.
28. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, Lannfelt L A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat Genet. 1:1992;345-347.
29. Murrell J, Farlow M, Ghetti B, Benson MD A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 254:1991;97-99.
30. Haass C, Hung AY, Selkoe DJ, Teplow DB Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β protein precursor. J Biol Chem. 269:1994;17741-17748.
31. Cai XD, Golde TE, Younkin SG Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science. 259:1993;514-516.
32. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature. 360:1992;672-674.
33. De Strooper B, Simons M, Multhaup G, Van Leuven F, Beyreuther K, Dotti CG Production of intracellular amyloid containing fragments in hippocampal neurons expressing human amyloid precursor protein and protection against amyloidogenesis by subtle amino acid substitutions in the rodent sequence. EMBO J. 14:1995;4932-4938.
34. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara I Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron. 13:1994;45-53.
35. Jarrett JT, Lansbury PT Jr Seeding 'one-dimensional crystallization' of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 73:1993;1055-1058.
36. De Strooper B, Umans L, Van Leuven F, Van Den Berghe H Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway. J Cell Biol. 121:1993;295-304.
37. Garvey W, Fathi A, Bigelow F, Jimenez CL, Carpenter BF Rapid, reliable and economical silver stain for neurofibrillary tangles and senile plaques. J Histotechnol. 14:1991;39-42.
38. Churukian CJ, Kazee AM, Lapham LW, Eskin TA Microwave modification of Bielschowsky silver impregnation method for diagnosis of Alzheimer's disease. J Histotechnol. 15:1992;299-302.
39. Hilbich C, Mönning U, Grund C, Masters CL, Beyreuther K Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein specific monoclonal antibody 22C11. J Biol Chem. 268:1993;26571-26577.
40. Simons M, De Strooper B, Multhaup G, Tienari PJ, Dotti CG, Beyreuther K Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons. J Neurosci. 16:1996;899-908.
41. Kim S, Miller D, Sapienza V, Chen C, Bai C, Grundke-Iqbal I, Currie J, Wisniewski H Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun. 2:1988;121-130.
42. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, Lieberburg I, Koo EH, Schenk D, Teplow DB, Selkoe DJ Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-325.
43. Shoji J, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, Cai XD, McKay DM, Tintner R, Frangione B, Younkin S Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science. 258:1992;126-129.
44. Sherriff FE, Bridges LR, Jackson P Microwave antigen retrieval of β-amyloid precursor protein immunoreactivity. Neuroreport. 5:1994;1085-1088.
45. Sloviter RS A simplified Timm stain procedure compatible with formaldehyde fixation and routine paraffin embedding of rat brain. Brain Res Bull. 8:1982;771-774.
46. Walsh RN, Cummins RA The open-field test: a critical review. Psychol Bull. 83:1976;482-504.
47. Supple WF Jr, Leaton RN, Fanselow MS Effects of cerebellar vermal lesions on species-specific fear responses, neophobia and taste-aversion learning. Physiol Behav. 39:1987;579-586.
48. Velley L, Mormede P, Kempf E Neurochemical lesion of the nucleus locus coeruleus increases neophobia in a specific exploration task but does not modify endocrine response to moderate stress. Pharmacol Biochem Behav. 29:1988;1-7.
49. Crusio WE, Schwegler H, van Abeelen JH Behavioral responses to novelty and structural variation of the hippocampus in mice. II. Multivariate genetic analysis. Behav Brain Res. 32:1989;81-88.
50. Plaznik A, Palejko W, Nazar M, Jessa M Effects of antagonists at the NMDA receptor complex in two models of anxiety. Eur Neuropsychopharmacol. 4:1994;503-512.
51. Griebel G, Moreau JL, Jenck F, Misslin R, Martin JR Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. Psychopharmocology. 113:1994;463-470.
52. Barger SW, Fiscus RR, Ruth P, Hofmann F, Mattson MP Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of the β-amyloid precursor. J Neurochem. 64:1995;2087-2096.
53. Risse SL, Lampe TH, Bird TD, Nochlin D, Sumi SM, Keenan T, Cubberley L, Peskind E, Raskind MA Myoclonus, seizures and paratonia in Alzheimer disease. Alzheimer Dis Assoc Disord. 4:1990;217-225.
54. Romanelli MF, Morris JC, Ashkin K, Coben LA Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol. 47:1990;847-850.
55. Lampe TH, Bird TD, Nochlin D, Nemens E, Risse SC, Sumi SM, Koerker R, Leaird B, Wier M, Raskind M Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol. 36:1994;368-378.
56. Kennedy AM, Newman S, McCaddon A, Ball J, Roques P, Mullan M, Hardy J, Chartier-Harlin M-C, Frackowiak RS, Warrington EK, Rossor MN Familial Alzheimer's disease: a pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine glycine). Brain. 116:1993;309-324.
57. Mullan M, Tsuji S, Miki T et al. Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val Ile mutation in the amyloid precursor protein gene. Neurobiol Aging. 14:1993;407-419.
58. Albin RL, Greenamyre JT Alternative excitotoxic hypotheses. Neurology. 42:1992;733-738.
59. Beal MF Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol. 31:1992;119-130.
60. Koh JY, Yang LL, Cotman CW Amyloid protein increases the vulnerability of cortical neurons to excitotoxic damage. Brain Res. 533:1990;315-320.
61. Aarsland D, Cummings JL, Yenner G, Miller B Relationship of aggressive behavior to other neuropsychiatric symptoms in patients with Alzheimer's disease. Am J Psychiatry. 153:1996;243-247.
62. Mega MS, Cummings JL, Fiorello T, Gornbein J The spectrum of behavioral changes in Alzheimer's disease. Neurology. 46:1996;130-135.